RocketDNA Statistics
Total Valuation
RocketDNA has a market cap or net worth of AUD 9.16 million. The enterprise value is 6.72 million.
Market Cap | 9.16M |
Enterprise Value | 6.72M |
Important Dates
The next estimated earnings date is Wednesday, May 28, 2025.
Earnings Date | May 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
RocketDNA has 915.52 million shares outstanding. The number of shares has increased by 31.00% in one year.
Current Share Class | n/a |
Shares Outstanding | 915.52M |
Shares Change (YoY) | +31.00% |
Shares Change (QoQ) | +8.01% |
Owned by Insiders (%) | 18.24% |
Owned by Institutions (%) | 26.58% |
Float | 611.43M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.26 |
PB Ratio | 1.56 |
P/TBV Ratio | 1.89 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.49 |
EV / Sales | 0.93 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -4.61 |
Financial Position
The company has a current ratio of 3.16, with a Debt / Equity ratio of 0.23.
Current Ratio | 3.16 |
Quick Ratio | 2.86 |
Debt / Equity | 0.23 |
Debt / EBITDA | n/a |
Debt / FCF | -0.92 |
Interest Coverage | -5.31 |
Financial Efficiency
Return on equity (ROE) is -36.75% and return on invested capital (ROIC) is -14.94%.
Return on Equity (ROE) | -36.75% |
Return on Assets (ROA) | -12.80% |
Return on Invested Capital (ROIC) | -14.94% |
Return on Capital Employed (ROCE) | -23.06% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.96 |
Inventory Turnover | 24.30 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +25.00% in the last 52 weeks. The beta is 0.26, so RocketDNA's price volatility has been lower than the market average.
Beta (5Y) | 0.26 |
52-Week Price Change | +25.00% |
50-Day Moving Average | 0.01 |
200-Day Moving Average | 0.01 |
Relative Strength Index (RSI) | 50.89 |
Average Volume (20 Days) | 959,186 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, RocketDNA had revenue of AUD 7.24 million and -1.92 million in losses. Loss per share was -0.00.
Revenue | 7.24M |
Gross Profit | 3.64M |
Operating Income | -1.55M |
Pretax Income | -1.79M |
Net Income | -1.92M |
EBITDA | -825,524 |
EBIT | -1.55M |
Loss Per Share | -0.00 |
Balance Sheet
The company has 3.45 million in cash and 1.34 million in debt, giving a net cash position of 2.11 million or 0.00 per share.
Cash & Cash Equivalents | 3.45M |
Total Debt | 1.34M |
Net Cash | 2.11M |
Net Cash Per Share | 0.00 |
Equity (Book Value) | 5.85M |
Book Value Per Share | 0.01 |
Working Capital | 3.49M |
Cash Flow
In the last 12 months, operating cash flow was -506,326 and capital expenditures -952,106, giving a free cash flow of -1.46 million.
Operating Cash Flow | -506,326 |
Capital Expenditures | -952,106 |
Free Cash Flow | -1.46M |
FCF Per Share | -0.00 |
Margins
Gross margin is 50.22%, with operating and profit margins of -21.45% and -26.57%.
Gross Margin | 50.22% |
Operating Margin | -21.45% |
Pretax Margin | -24.66% |
Profit Margin | -26.57% |
EBITDA Margin | -11.40% |
EBIT Margin | -21.45% |
FCF Margin | n/a |
Dividends & Yields
RocketDNA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -31.00% |
Shareholder Yield | -31.00% |
Earnings Yield | -21.01% |
FCF Yield | -15.93% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
RocketDNA has an Altman Z-Score of 0.74. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.74 |
Piotroski F-Score | n/a |